We have reported that normal human salivary gland-derived epithelial cells exclusively express keratinocyte growth factor receptor (KGFR). In the process of malignant transformation of human salivary gland tumors, KGFR gene expression disappeared concomitantly with the de novo expression of the fibroblast growth factor receptor 1 (FGFR1) and FGFR4 genes. In the present study, we introduced wild-type KGFR cDNA or chimeric KGFR͞ FGFR1 cDNA, which encoded the extracellular domain of KGFR and the intracellular domain of FGFR1, into the HSY human salivary adenocarcinoma cell line. The KGFR tyrosine kinase suppressed the activity of FGF receptor substrate 2 (FRS2) and inhibited the growth of HSY by inducing differentiation and apoptosis in vitro and in vivo. Our results provided significant insight into the mechanism of KGFR tumor suppression and suggest that KGFR gene therapy might be a viable method of inhibiting human salivary adenocarcinoma growth. K eratinocyte growth factor (KGF͞FGF7) is a member of the fibroblast growth factor (FGF) family (1). Its activity is largely restricted to epithelial cells, which express the KGF receptor (KGFR), a transmembrane tyrosine kinase encoded by the IIIb splice variant of FGFR2 (FGFR2-IIIb) (2, 3). KGFR binds KGF and FGF-1 with high affinity. In contrast, FGFR2-IIIc, another splice variant of FGFR2, binds FGF-1 and FGF-2, but not KGF (3, 4). Analysis of KGF and KGFR expression during embryonic development, including that of mammary glands, has provided evidence that KGF is an important mesenchymal mediator of epithelial growth and differentiation. In normal human skin, KGFR immunostaining localizes to the suprabasal layers (5, 6). The lack of KGFR in basal cell progenitors in skin suggests that KGFR might regulate keratinocyte differentiation (7).
K
eratinocyte growth factor (KGF͞FGF7) is a member of the fibroblast growth factor (FGF) family (1) . Its activity is largely restricted to epithelial cells, which express the KGF receptor (KGFR), a transmembrane tyrosine kinase encoded by the IIIb splice variant of FGFR2 (FGFR2-IIIb) (2, 3) . KGFR binds KGF and FGF-1 with high affinity. In contrast, FGFR2-IIIc, another splice variant of FGFR2, binds FGF-1 and FGF-2, but not KGF (3, 4) . Analysis of KGF and KGFR expression during embryonic development, including that of mammary glands, has provided evidence that KGF is an important mesenchymal mediator of epithelial growth and differentiation. In normal human skin, KGFR immunostaining localizes to the suprabasal layers (5, 6) . The lack of KGFR in basal cell progenitors in skin suggests that KGFR might regulate keratinocyte differentiation (7) .
Malignant salivary tumors are highly aggressive neoplasms that readily invade adjacent tissues and metastasize to distant organs at early stages of the disease. Malignant salivary tumors exhibit enhanced expression of both FGF-1 and FGF-2 compared with normal salivary gland (8) . FGF-1 and FGF-2 can act in an autocrine manner to stimulate the proliferation of salivary adenocarcinoma cells (8, 9) . Normal salivary gland epithelial cells and benign salivary gland tumors exclusively express the KGFR gene. During the malignant transformation of salivary gland epithelial cells, the expression of the KGFR gene is abolished, whereas the FGFR1-IIIc and FGFR4 genes are activated (10) . The exclusive expression of the KGFR gene in both normal and premalignant salivary epithelial cells correlates well with the slow-growing and differentiated phenotype of premalignant tumors. In contrast, the loss of the KGFR gene and the expression of both the FGFR1 gene and its specific ligand FGF-2 in malignant tumor cells are associated with the emergence of the malignant phenotype. Thus, the loss of normal KGFR gene function may promote tumorigenicity, whereas KGFR may function to suppress human salivary adenocarcinomas.
The Ras-MAP kinase signaling pathway plays an important role in signaling via FGFRs (11, 12) . It is now well established that the lipid-anchored docking protein FGF receptor substrate 2 (FRS2) links FGFR molecules with the Ras-MAP kinase signaling pathway by forming a complex with the N-terminal SH2 domain of the protein tyrosine phosphatase Shp2 and the adaptor protein Grb2. Blocking FRS2 signaling results in weak Ras-MAP kinase phosphorylation (13, 14) . In the present study, we found that the wild-type KGFR gene transferred into HSY human salivary adenocarcinoma cells caused a decreased level of tyrosine-phosphorylated activity of FRS2, resulting in apoptosis and differentiation in vitro and in vivo. Our data provide insight into the mechanism of KGFR tumor suppression.
Materials and Methods
Cell Culture and Recombinant DNA Constructs. Normal salivary gland-derived epithelial (SGE) cells were isolated from human submandibular glands and cultured in serum-free medium as described (15) . The human salivary adenocarcinoma cell line HSY (16) was kindly provided by Professor Mitsunobu Sato (Second Department of Oral and Maxillofacial Surgery, Tokushima University School of Dentistry, Tokushima, Japan). HSY was maintained in RD medium (RPMI 1640 medium͞ DMEM, 1:1) supplemented with 5% calf serum as described (10) .
KGFR carrying full-length FGFR2-IIIb cDNA and chimeric KGFR͞FGFR1 carrying the extracellular domain of KGFR and the intracellular domain of FGFR1 were cloned into mammalian expression vector pcDNA3.1͞zeo (Invitrogen) as described (17) .
For transfection, 60% confluent HSY cells were preincubated with serum-and antibiotic-free RD medium for 2 h, then transfected with wild-type KGFR or chimeric KGFR͞FGFR1 cDNAs by a liposome-mediated method with the use of Lipofectamine Plus Reagent (GIBCO͞BRL and Life Technologies, Rockville, MD). As a control, pcDNA3.1͞zeo bearing no cDNA insert was introduced. The cells were then selected with 400 g͞ml of Zeocin (Invitrogen) for 2 weeks, and the colonies of cells emerging from the selection medium were isolated and Abbreviations: FGF, fibroblast growth factor; FGFR, fibroblast growth factor receptor; KGF, keratinocyte growth factor; KGFR, keratinocyte growth factor receptor; FRS2, FGF receptor substrate 2; Grb2, growth factor receptor-bound protein 2; MAP, mitogen-activated protein; SGE cells, salivary gland-derived epithelial cells; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling. ¶ To whom reprint requests should be addressed. E-mail: tetsuok@hiroshima-u.ac.jp.
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further selected by RRA with 125 I-KGF as described (18) . KGFR-overexpressing HSY cells were designated HSYR2-IIIb, KGFR͞FGFR1-overexpressing HSY cells were designated HSYR2͞R1, and the control transfectants were designated HSYzeo.
Cell Proliferation Assay. For the study of population growth rates, HSYzeo, HSYR2͞R1, and HSYR2-IIIb cells (1 ϫ 10 4 cells per well) were seeded into type I collagen (Cell Matrix type I-A; Nitta Gelatin Co., Osaka, Japan)-coated 24-well culture plates, respectively, in serum-free RD medium containing 10 g͞ml bovine insulin, 5 g͞ml human transferrin, 10 M mercaptoethanol, 10 M 2-aminoethanol, and 10 nM sodium selenite (RD5F) (19) . Cell numbers were counted daily for 6 days.
To evaluate the effect of FGF on the growth of the transfectants in serum-free culture, HSYzeo, HSYR2͞R1, and HSYR2-IIIb cells (3 ϫ 10 3 cells per well) were seeded in RD5F and incubated with the indicated concentrations of FGF-1, FGF-2, or KGF for 5 days. FGF-1 was purified from bovine brain, and rat recombinant KGF was prepared as described (20, 21) . Human recombinant FGF-2 was purchased from Upstate Biotechnology (Lake Placid, NY). Cell numbers were measured with a Coulter Counter (Coulter Electronics, Hialeah, FL).
Immunocytochemical Analysis. To determine whether transfectants were undergoing differentiation, the salivary gland differentiation markers ␣-amylase and lactoferrin were analyzed immunocytochemically. Briefly, the cells were cultured in RD5F without KGF on Lab-Tek II chamber slides (Nalgen Nunc International, Naperville, IL) for 2 days, then the cells were fixed with freshly prepared 2% paraformaldehyde for 30 min. After blocking with 10% normal goat serum for 30 min, the cells were incubated with rabbit anti-amylase antibody (Dako) diluted by 1:100 or rabbit anti-lactoferrin antibody (Dako) diluted by 1:100. Immunodetection of the antigens was performed with the Elite Avidin-Biotin-Immunoperoxidase System (Vector Laboratories) according to the manufacturer's instructions. Staining of the cells was graded as follows: 0-1ϩ, negative to indeterminate cell staining; 2ϩ, weak but clearly positive cell staining; 3ϩ, strong cell staining.
Detection of Apoptotic DNA Fragmentation. The cells (10 4 cells per milliliter) were cultured in serum-free RD5F with 20 ng͞ml KGF on 10 cm 2 dish (10 dishes per experiment point). DNA was extracted from the adherent and floating cells every day for 7 days as described (22) . DNA samples were electrophoresed on 2% agarose gel and visualized by ethidium bromide staining to detect DNA fragmentation.
Tumor Cell Implantation and Histochemical Analysis. One hundred and five female athymic mice (BALB͞c, AnNCrj-nu͞r, 5 weeks old) were used for this study. The research protocol was approved, and mice were maintained in accordance with institutional guidelines of the Hiroshima University Animal Care and Use Committee. Five mice per clone were used per experiment. In each experiment, 35 mice were used. The cells (2 ϫ 10 6 ) suspended in 100 l of PBS were injected s.c. in the lateral back region. Tumor volume (V) was measured twice a week, according to the formula V ϭ 1͞2 ϫ length ϫ width 2 ). Mice were killed by cervical dislocation 4 weeks after inoculation. For histochemical analysis, the tumor tissues were fixed in freshly prepared 4% paraformaldehyde and embedded in paraffin. Tissues were sectioned and stained with hematoxylin͞eosin.
Terminal Deoxynucleotidyl Transferase-Mediated dUTP-Biotin NickEnd Labeling (TUNEL) Assay. Paraffin sections (4-6 m) of tumor specimen were digested with proteinase K (20 g͞ml) for 5 min at 37°C and then incubated with terminal deoxynucleotidyl transferase enzyme (Wako Pure Chemical, Osaka) for 60 min at 37°C. After being treated with 3% H 2 O 2 for 5 min at room temperature, the sections were incubated with peroxidaseconjugated antibody (Wako Pure Chemical, Osaka) for 60 min at 37°C. The reaction was visualized with diaminobenzidine-H 2 O 2 substrate.
Analysis of FRS2 Phosphorylation. The cells were nutrition-starved for 24 h and then incubated with 20 ng͞ml of FGF-1, FGF-2, or KGF for 5 min at 37°C. The cells were washed three times with cold PBS containing 1 mM Na 3 VO 4 and lysed with lysis buffer (50 mM Hepes͞1% Triton X-100͞10% glycerol͞150 mM NaCl͞ 100 mM NaF͞1.5 mM MgCl 2 ͞1 mM EGTA͞1 mM Na 3 VO 4 ͞1 mM phenylmethylsulfonyl fluoride͞10 g/ml aprotinin). The sonicated and clarified cell lysates (500 g per sample) were immunoprecipitated with 3 g of rabbit anti-Grb2 antibody (Transduction Laboratories, Lexington, KY) overnight at 4°C, and then the antigen-antibody complexes were recovered by a 2-h incubation with protein A-Sepharose CL-4B (Amersham Pharmacia) at 4°C. The immunoprecipitated samples were electrophoresed on 7.5% SDS͞polyacryamide gel under reducing conditions and transferred to Immobilon-P membrane (Millipore). The membrane was incubated with a 1:1,000 dilution of anti-phosphotyrosine monoclonal antibody 4G10 (Upstate Biotechnology) or a 1:1,000 dilution of goat anti-FRS2 antibody (Santa Cruz Technology) overnight at 4°C. Immunodetection of the antigen was performed with the 5-bromo-4-chloro-3-indolyl phosphate͞nitroblue tetrazolium Membrane Phosphatase Substrate System (Kirkegaard & Perry Laboratories) according to the manufacturer's instructions.
Statistical Analysis. Immunocytochemical results were analyzed with the use of contingency tables and the Kruskal-Wallis rank test. ANOVA and Tukey's test were used for other data. Significance was defined as P Ͻ 0.05. The statistical software used was STATVIEW 5.0 (SAS Institute, Cary, NC).
Results
Differential Growth of Transfectants. Among 58 Zeocin-resistant HSYR2-IIIb clones and 50 Zeocin-resistant HSYR2͞R1 clones, seven HSYR2-IIIb clones and seven HSYR2͞R1 clones were selected for analysis because they exhibited higher KGFR numbers ( Table 1 ). The transfected cell line HSYR2-IIIb proliferated with a doubling time of 52 h (SD 1.9), whereas HSYzeo and HSYR2͞R1 proliferated with doubling times of 18 h and 19 h (SD 1.2 and 1.7), respectively ( Table 1 ). The growth rate of HSYR2-IIIb cells was significantly lower than those of HSYzeo and HSYR2͞R1 (P Ͻ 0.001; Fig. 1 ). FGF-1 at 20 ng͞ml showed a 4-fold stimulation of HSYzeo growth and a 2.5-fold stimulation of HSYR2͞R1 growth in serum-free culture ( Fig. 2A) . FGF-2 at 20 ng͞ml showed a 4.8-fold stimulation of HSYzeo and a 2.5-fold stimulation of HSYR2͞R1 growth in serum-free culture (Fig.  2B) . The growth of HSYR2-IIIb was not stimulated by either FGF-1 or FGF-2 (Fig. 2) . Although HSYR2͞R1 and HSYR2-IIIb expressed KGFR, KGF did not have a mitogenic effect on HSYR2͞R1 or HSYR2-IIIb.
Cellular Differentiation and Apoptosis in HSYR2-IIIb in Vitro. By immunocytochemical analysis HSYzeo and HSYR2͞R1 cells exhibited negative to weakly positive staining for ␣-amylase and lactoferrin, whereas HSYR2-IIIb cells were strongly positive for both ␣-amylase and lactoferrin in the cytoplasm and perinuclear regions (Fig. 3) .
HSYR2-IIIb cells detached from the culture plates over a 4-day serum-free culture period with 20 ng͞ml KGF and eventually died. By trypan blue dye exclusion, Ϸ10% of the cells detached and died on day 2, 15% on day 3, 50% on day 4, and 90% on day 7. TUNEL positive cells were observed in HSYR2-IIIb, although no TUNEL positive cells were detected in HSYzeo or HSYR2͞R1. On the third day of culture with KGF, 15% of HSYR2-IIIb was positive for TUNEL staining, and 70% were positive for TUNEL staining on day 7. Compaction and margination of nuclear chromatin, condensation of cytoplasm, and convolution of nuclear and cell outlines were observed in cultured HSYR2-IIIb (data not shown). No detectable fragmentation was observed in DNA derived from HSYzeo and HSYR2͞R1 cultured with KGF (20 ng͞ml) for 7 days. On the other hand, DNA laddering was observed in DNA derived from HSYR2-IIIb cultured with KGF (20 ng͞ml) for 4 days, and it increased markedly over a 7-day period (Fig. 4) .
Differentiation and Apoptosis in HSYR2-IIIb in Vivo.
Because KGFR was able to inhibit the growth of HSY in vitro, we attempted to determine whether KGFR expression suppressed the tumorigenicity of HSY cells. There was no significant difference between the tumor growth of HSYzeo and HSYR2͞R1 (P Ͼ 0.05). In contrast, there was a significant reduction in growth rate of HSYR2-IIIb-derived tumors compared with that of HSYzeoand HSYR2͞R1-derived tumors (P Ͻ 0.001, Fig. 5A , Table 1 ), and three of seven HSYR2-IIIb clones lost their tumorigenicity ( Table 1 ). The HSYR2-IIIb-derived tumors were much smaller, softer, and paler in comparison with HSYzeo-derived tumors; they exhibited rounded structures with smooth surfaces; and they were well encapsulated and demarcated from the surrounding connective tissues. HSYzeo-and HSYR2͞R1-derived tumors had an irregular rounded appearance with lobulated or multinodular surfaces. The connective tissue, which is abundant in vascularization, did not completely encapsulate the tumors (data not shown). Histologically, tumors developed from HSYR2-IIIb exhibited prominent duct-like and acinar-like structures surrounded by stromal cells (Fig. 5B1) . Furthermore, in some undifferentiated areas, DNA fragmentation and apoptotic bodies were observed in the nuclei of HSYR2-IIIb-derived tumors (Fig. 5B2) . HSYzeo-and HSYR2͞R1-derived tumors exhibited typical adenocarcinomas with a solid and trabecular pattern ( Fig.  5 B3 and B4 ).
Differential Kinase Phosphorylation. As FRS2 is essential for FGFinduced DNA synthesis (13), we assessed the phosphorylation state of FRS2 after FGF stimulation in different transfectants and SGE cells. FRS2 was identified as a tyrosine-phosphorylated protein in HSYzeo and HSYR2͞R1 cells stimulated with FGF1 and FGF2, but not in HSYR2-IIIb and SGE cells (Fig. 6 ). On stimulation with FGF-1 and FGF-2, p38 MAP kinase was strongly activated in HSYzeo and HSYR2͞R1 cells, but not in HSYR2-IIIb or SGE (data not shown). Moreover, the proliferation of HSYzeo and HSYR2͞R1 was inhibited significantly in the presence of the specific p38 MAP kinase inhibitor SB203580 (data not shown).
Discussion
In the present study, we have demonstrated that the wild-type KGFR gene transferred into HSY human salivary adenocarcinoma cells induced differentiation and apoptosis, while suppressing tumor cell growth in vitro and inhibiting tumor growth in athymic mice. Apoptosis, or programmed cell death, is a fundamental process in organ development and tissue homeostasis in complex organisms (23) . The induction of apoptosis has been widely used as an approach to cancer therapy (24) . The morphological hallmarks of apoptosis, including membrane blebbing, volume loss, nuclear condensation, and DNA fragmentation, were all observed when a wild-type KGFR gene was transfected into HSY salivary adenocarcinoma cells. The apoptosis of HSYR2-IIIb cells was observed during a 7-day culture in KGF. Furthermore, endogenous DNA fragmentation and apoptotic bodies were observed in HSYR2-IIIb-derived tumors in athymic mice. These results describe a mechanism of blocking tumor growth in which restoration of KGFR tyrosine kinase activity in HSY cells induces apoptosis on stimulation by its ligand KGF.
␣-Amylase and lactoferrin are major secretory products of human salivary glands that serve as markers of acinar cell and ductal cell differentiation, respectively (25) (26) (27) . Immunocytochemical analysis indicated that the expression level of ␣-amylase and lactoferrin in HSYR2-IIIb was much higher than that in HSYzeo and HSYR2͞R1 even without KGF. Histological examination revealed that predominant duct-like, acinar-like structures and apoptotic cells were always observed closely opposed to stromal cells in HSYR2-IIIb-derived tumors. These results suggest that the tyrosine kinase of KGFR is very important for cellular differentiation and that the communication between stromal cells and epithelial cells was involved in the induction of cellular differentiation.
The growth of HSYzeo and HSYR2͞R1 was stimulated by either FGF-1 or FGF-2, but not by KGF. In contrast, the growth of HSYR2-IIIb was not stimulated by FGF-1, FGF-2, or KGF. We found that FGFR1 and FGFR4 were still expressed in HSYR2-IIIb by reverse transcription-PCR analysis (data not shown). How does KGFR tyrosine kinase alter the signaling of FGF-1 and FGF-2 to inhibit tumor growth? Like many other growth factor receptors, KGFR, when overexpressed, may be easily autophosphorylated in the absence of ligand (28, 29) . Our results showed that the differentiation and apoptosis of HSYR2-IIIb cells occurred even in the absence of KGF and were further accelerated in the presence of KGF. Stimulation of cell proliferation and differentiation by FGF receptors depends on the Ras-MAP kinase signal pathway (30, 31) . FRS2 plays an important role in linking FGF with Ras-MAP kinase signaling. In response to FGF stimulation, FGF receptors bind to Grb2 to become tyrosine-phosphorylated by FRS2. It has been shown that FGF-induced DNA synthesis can be inhibited by microinjection of anti-FRS2 antibody (13) . Moreover, an FRS2 mutant impaired Grb2 binding and failed to induce neuronal differentiation of PC12 cells (14) . In the present study, either FRS2 or p38 MAP kinase was identified as a phosphorylated protein in HSYzeo and HSYR2͞R1, but not in HSYR2-IIIb or SGE cells on stimulation by FGFs. These results demonstrated that the tyrosine kinase of KGFR suppresses the phosphorylation of FRS2 and blocks p38 MAP kinase signaling. Moreover, the specific p38 MAP kinase inhibitor SB203580 inhibited the proliferation of HSYzeo and HSYR2͞R1, suggesting that the blocking of p38 MAP kinase may be one mechanism by which the restoration of KGFR tyrosine kinase inhibits adenocarcinoma cell growth.
We have reported that FGF-1 and KGF stimulated the growth of SGE cells (10) ; however, tyrosine phosphorylation of FRS2 was not observed in SGE. The result implies that FGF stimulates proliferation of normal epithelial cells and malignant cells by distinct signaling pathways.
The progressive loss of KGFR expression has been implicated in the malignant progression of many tumors, including human bladder tumors (32) and prostate tumors (33) . It has also been demonstrated that restoration of KGFR tyrosine kinase induced the differentiation of malignant cells and inhibited the growth of human bladder carcinomas and malignant rat prostate carcinomas (32, 34) . However, the mechanism by which the KGFR gene inhibits malignant cell growth was not elucidated. Our findings demonstrate that the restoration of KGFR tyrosine kinase in human adenocarcinoma cells caused decreased levels of FRS2 phosphorylation and led to induction of apoptosis and differentiation. These results suggest that KGFR gene therapy might be a viable approach to inhibiting the growth of salivary adenocarcinomas. 
